DaVita Inc. (BVMF:DVAI34)

Market Cap	48.98B -40.3%
Revenue (ttm)	75.15B +6.5%
Net Income	4.11B -20.2%
EPS	54.20 -8.3%
Shares Out	n/a
PE Ratio	11.91
Forward PE	10.13
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Average Volume	279
Open	714.00
Previous Close	743.75
Day's Range	714.00 - 714.00
52-Week Range	546.63 - 1,022.67
Beta	1.01
RSI	58.34
Earnings Date	Feb 2, 2026

About DaVita

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1994
• Employees: 76,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: DVAI34

Financial Performance

In 2025, DaVita's revenue was $13.64 billion, an increase of 6.46% compared to the previous year's $12.82 billion. Earnings were $746.80 million, a decrease of -20.24%.

Financial numbers in USD